Form 4: Director Shelley Broader Increases Stake in Inspire Medical

Director Shelley G. Broader acquired 342 shares of Inspire Medical Systems, Inc. common stock in lieu of cash director fees.

Summary

• Director Shelley G. Broader acquired 342 shares of common stock on April 15, 2026.
• The shares were issued at a price of $52.07 per share.
• The acquisition was made in lieu of cash compensation pursuant to the company's Non-Employee Director Compensation Policy.
• Following this transaction, the director's total beneficial ownership is 4,909 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Demonstrates alignment of interest between the director and shareholders through equity ownership.
• Reflects confidence in the company's long-term value by opting for stock over cash compensation.

Future Outlook

Not applicable as this is a routine disclosure of director compensation.

Industry Context

StockSavvy.ai notes that it is common practice for medical device companies to offer equity-based compensation to directors to preserve cash and ensure long-term alignment with corporate performance.

Comparison to Industry Standards

• The practice of issuing stock in lieu of cash fees is a standard corporate governance mechanism used by many mid-cap healthcare and medical technology firms to manage liquidity and incentivize board members.

Corporate Governance

Stakeholder Impact

• Shareholders benefit from increased insider alignment.

Key Dates

Keywords

Inspire Medical Systems, INSP, Form 4, Insider Trading, Director Compensation, Equity Ownership